Searchdog Unveils AI Platform for Drawings, Courts North American Clients
Korean AI startup Searchdog unveiled an AI platform for integrated analysis of CAD drawings, BIM data, and large industrial documents. The company showcased its technology at Autodesk University 2026 in Las Vegas. Searchdog aims to secure proof-of-concept projects with North American clients. Its platform helps users search, compare, and verify complex industrial data using natural language.
Searchdog's platform integrates document analysis with CAD and BIM data, a necessary step for complex industrial projects. The focus on extracting and linking clauses, tables, and revision histories with object and geometry information addresses a real pain point. Automating compliance reviews against national regulations and project owner requirements offers a clear efficiency gain for AEC and manufacturing firms.
The move to target North American clients at Autodesk University 2026 shows Searchdog's ambition beyond its domestic market. Validating technology with major Korean construction companies provides a strong foundation. Success in the U.S. market would open doors for other Korean AI startups in industrial applications, particularly those with deep domain expertise in engineering and construction.
The real test for Searchdog is converting proof-of-concept projects into long-term contracts with U.S. clients. Demonstrating tangible ROI in bidding, design, and compliance tasks will be key. Watch whether Searchdog announces specific U.S. client wins by late 2027; this would confirm its ability to scale internationally.
Related reading
6 stories
Korea Bets 8.4 Trillion Won on Sodium, Solid-State Batteries
Korea's significant investment in advanced battery tech shows its broader commitment to industrial innovation.

Chinese maker of robot-vacuum sensors launches Hong Kong IPO, undeterred by US ban

Thunes Extends J.P. Morgan Payments Reach Across 100+ Corridors

Robo.ai Inc. Announces Results of Extraordinary General Meeting

Exclusive-Anthropic, OpenEvidence partner to bring medical AI worldwide

